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A monotone data augmentation algorithm for
multivariate nonnormal data: with applications
to controlled imputations for longitudinal trials
Yongqiang Tang
An efficient monotone data augmentation (MDA) algorithm is proposed for missing data imputation for incomplete
multivariate nonnormal data that may contain variables of different types, and are modeled by a sequence of
regression models including the linear, binary logistic, multinomial logistic, proportional odds, Poisson, negative
binomial, skew-normal, skew-t regressions or a mixture of these models. The MDA algorithm is applied to the
sensitivity analyses of longitudinal trials with nonignorable dropout using the controlled pattern imputations that
assume the treatment effect reduces or disappears after subjects in the experimental arm discontinue the treatment.
We also describe a heuristic approach to implement the controlled imputation, in which the fully conditional
specification method is used to impute the intermediate missing data to create a monotone missing pattern, and the
missing data after dropout are then imputed according to the assumed nonignorable mechanisms. The proposed
methods are illustrated by simulation and real data analyses. Copyright c© 2018 John Wiley & Sons, Ltd.
Keywords: Fully conditional specification; Generalized linear model; Markov chain Monte Carlo; Pattern
mixture model; Skew-normal and skew-t regression; Tipping point analysis
1. Introduction
Multiple imputation (MI) provides a popular and convenient way to analyze complex data with missing values [1]. A MI
procedure consists of three steps: 1) The missing values are imputed m times from their posterior predictive distribution
given the observed data on basis of an appropriate statistical model; 2) Each imputed dataset is analyzed by a standard
statistical method; 3) The results from m datasets are combined for inference by using Rubin’s rule [2]. An attractive
feature of MI is that the imputation and analysis models can be different. For example, in clinical trials, the surrogate
endpoints and auxiliary variables are often highly correlated with the primary efficacy endpoint and the dropout process,
and may be employed to improve the imputation of the primary efficacy outcomes [1, 3, 4, 5, 6], but it is difficult to
incorporate such information in the likelihood-based inference [5, 6].
TheMI methodology is well established for multivariate normal outcomes with an arbitrary missing pattern. An efficient
Markov chain Monte Carlo (MCMC) algorithm was developed by Schafer [7] by using the monotone data augmentation
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(MDA) technique. The MDA algorithm iterates between an imputation I-step, in which the intermittent missing data
are imputed given the current draw of the model parameters, and a posterior P-step, in which the model parameters
are updated given the current imputed monotone data. It tends to converge faster with smaller autocorrelation between
posterior samples than a full data augmentation algorithm that imputes both the intermittent missing data and missing data
after dropout during the I-step [7, 8]. Schafer’s algorithm was recently improved by Tang [9, 8]. Tang’s approach allows
the use of a more general prior distribution [9, 8], imputes the intermittent missing outcomes in a more computationally
efficient way [8], and enables more flexible modeling of the mean and covariance matrix [8].
For multivariate nonnormal data with a monotone missing pattern, imputation can be performed by the sequential
regression method [10]. The multivariate nonnormal data with an arbitrary missing pattern are generally imputed by the
MCMC method for multivariate normal outcomes [11, 12, 13] or by the fully conditional specification (FCS) method
[10, 14, 15, 12, 16] due to the lack of a natural multivariate distribution for these data. The former approach ignores the
non-normality in the data. The FCS, also known as “chained equations”, is an analogy to the traditional Gibbs sampling
scheme [17], and imputes the data on a variable-by-variable basis by specifying a conditional model for each variable with
all other variables as predictors. A theoretical weakness of FCS is that there does not in general exist a joint distribution
that is consistent with these conditional distributions [15, 18, 19], and its performance is evaluated mainly by simulations.
Multivariate data can be modeled by the sequential regression, copula models, random effects models or a combination
of these techniques [20]. The generalized estimating equation type approach may not be appropriate for missing data
imputation since it does not explicitly model the within subject dependence [21]. Formal MCMC algorithms have
been developed for multivariate nonnormal data under some special cases. Tang [22] developed MDA algorithms for
longitudinal binary and ordinal outcomes based respectively on a sequence of logistic regression and the multivariate
probit model, and the latter approach is a type of Gaussian copula model. Lee et. al. [23] proposed a full data augmentation
algorithm for the sequential regression. It allows binary, ordinal, nominal and continuous outcomes, and models the binary
and ordinal outcomes by the probit regression. Lee et. al. algorithm requires that the nominal outcomes be put before
other types of response variables, and therefore may not be suitable for longitudinal outcomes with a natural order among
variables. Goldstein et. al. [24] described an algorithm for multivariate data with a hierarchical structure (e.g. repeated
measures data at different visits nested within individuals) through the Gaussian copula-based random effects model, and
it allows binary, ordinal, nominal and continuous outcomes.
One main purpose of this article is to describe a MDA algorithm for multivariate nonnormal data on basis of a sequence
of regression models. Section 2.1 presents the algorithm when the models used contain only the generalized linear
models (GLM) such as the linear regression for normal outcomes, logistic regression for binary and nominal outcomes,
proportional odds model for ordinal outcomes, Poisson regression and negative binomial regression for count data, or a
mixture of these models. There is no restriction on the order of the response variables. The MDA algorithms of Tang
[8, 22] are special cases of the proposed algorithm when the data contain only one type of response variable (continuous,
binary, or ordinal). Section 2.2 extends the algorithm to incorporate the skew-normal and skew-t regressions for nonnormal
continuous outcomes, and discusses the potential extension to include other types of regression models.
In Section 2.3, we apply the proposed MDA algorithm to the controlled pattern imputations for sensitivity analyses
in longitudinal clinical trials. The missing at random (MAR) based analysis assumes that after treatment discontinuation,
patients still have the same statistical behaviors as otherwise similar subjects who remain in the trial. TheMARmechanism
is unrealistic particularly if the early discontinuation is due to lack of efficacy or safety issues. The regulatory guidelines
[25, 26] and a FDA-mandated panel report from the National Research Council [27] recommend sensitivity analysis
under missing not at random (MNAR) in the sense that the response profiles for subjects who withdraw are systematically
different from those who remain on the treatment. The controlled pattern imputations, pioneered by Little and Yau [3],
assume that the treatment effect reduces or disappears after the treatment discontinuation by taking into account of the
treatment actually received after dropout [28, 29, 30, 8, 22]. These methods have become increasingly popular in clinical
trials because the underlying MNAR assumption is clinically plausible and easy to interpret.
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Section 3 describes a heuristic approach to implement the controlled imputation. We employ FCS to impute the
intermediate missing data to create a monotone missing pattern. The missing data after withdrawal are then imputed
according to the assumed MNAR mechanisms. The proposed MDA and FCS imputation algorithms are illustrated by one
simulation study in Section 4, and by the analysis of two real trials in Section 5.
Throughout the article, we use the following notations. Let G(a, b) denote a gamma distribution with shape a, rate
b and mean a/b. Let N(µ, σ2) be the normal distribution, and N+(µ, σ2) the positive normal distribution (i.e. normal
distribution left truncated by 0). Let t(µ, σ2, ν) be the t distribution with mean µ, scale σ2, and ν degrees of freedom (d.f.),
and t+(µ, σ2, ν) the positive t distribution. Let tν(·) and Tν(·) denote respectively the probability density function (PDF)
and cumulative distribution function (CDF) of the standard Student’s t distribution with ν d.f.
2. MDA algorithm
Let yi = (yi1, . . . , yip)
′ denote the p response variables of interest, and xi = (xi1, . . . , xiq)
′ the covariates (xi1 ≡ 1 if the
model contains an intercept) for subject i = 1, . . . , n. We assume the covariates are fully observed. If a covariate contains
missing values, it can be treated as a response variable. In general, yi’s are partially observed. Let si be the dropout pattern
according to the index of the last observation for subject i. We have si = 0 for subjects whose responses are all missing,
and si = p if yip is observed.
Let yio, yic, yid and yiw denote respectively the observed data, intermittent missing continuous data, intermittent
missing discrete data, and the missing data after the last observed value for subject i. Let Yo = {yio : i = 1, . . . , n},
Yd = {yid : i = 1, . . . , n}, Yc = {yic : i = 1, . . . , n}, and Yw = {yiw : i = 1, . . . , n}. Without loss of generality, we sort
the data so that subjects in pattern s are arranged before subjects in pattern t if s > t. Let nj be the total number of subjects
in patterns j, . . . , p.
2.1. MDA algorithm based on a sequence of generalized linear models
Suppose the joint distribution of yi = (yi1, . . . , yip)
′ can be factored as f(yi1, . . . , yip) =
∏p
j=1 fj(yij |zij ,βj , φj), where
zi1 = xi, zij = (x
′
i, yi1, . . . , yij−1)
′ at j ≥ 2, βj is a vector of regression coefficients, and φj is the dispersion parameter
(e.g. variance in linear regression). In practice, the relationship between yj and zij is usually modeled by GLM [31, 32]
fj(yij |zij ,βj, φj) = exp
[
yijθj − b(θj)
a(φj)
+ c(yij , φj)
]
, (1)
where θj is the canonical parameter. For example, the binary outcome is often analyzed by the logistic regression, and
count data may be fitted by Poisson or negative binomial regressions. Appendix A.1 lists several commonly used GLMs
and provides technical details for the MDA algorithm. In GLM [31, 32], yij has mean µij =
∂b(θj)
∂θj
and variance Vij =
∂µij
∂θj
a(φj). A link function ηij = g(µij) is used to relate µij to the predictor variables in zij . For notational simplicity,
we assume yij’s are scalar, and ηij = z
′
ijβj =
∑q
k=1 xikαjk +
∑j−1
k=1 βjkyik, where βj = (αj1, . . . , αjq, βj1, . . . , βj,j−1)
′.
But yij can be a vector. For example, a nominal variable with k levels is typically coded as k − 1 indicator variables.
Furthermore, interactions between predictors are allowed, and there is no need to include all variables in zij as predictors
in model (1) particularly when the number of response variables p is large.
The likelihood for the augmented monotone data (Yo, Yd, Yc) is
L(β1, φ1, . . . ,βp, φp|Yo, Yd, Yc) ∝
p∏
j=1
nj∏
i=1
fj(yij |zij ,βj, φj).
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We use independent priors for (βj , φj)’s. They are also independent in the posterior distribution
π(βj , φj |Yo, Yd, Yc) ∝ π(βj , φj)
nj∏
i=1
fj(yij |zij ,βj , φj). (2)
Throughout, we use π(·) and π(·|·) to denote respectively the prior and posterior densities.
The proposed MDA algorithm (labeled as A) involves repeating the following steps until convergence
A.1: Draw (βj , φj)’s from their posterior distribution (2) given Yo and the current imputed (Yd, Yc).
A.2: Impute intermittent missing data for subject i = 1, . . . , n given Yo and the current draw of (βj , φj)’s.
A.2.1: Impute yid given (yio,yic) and (βj , φj)’s.
A.2.2: Impute yic given (yio,yid) and (βj , φj)’s.
The missing data yiw’s after the last observed value are imputed after the posterior samples (βj , φj)’s and (Yd, Yc) in steps
A.1 and A.2 converge to their stationary distribution [8, 30]. The details will be given in Section 2.3.
2.1.1. Draw of the model parameters in Step A.1: The draw of (βj , φj) in Step A.1 presents little challenge since it is
identical to that in the univariate regression. In the linear regression, the posterior distribution of (βj , φj) is normal-gamma
[9, 30, 8], and (βj , φj) can be drawn by the Gibbs sampler described in Appendix A.2.2. The sampling of φj depends on
the specific model. In general, βj can be drawn via Gamerman’s [33] Metropolis-Hastings (MH) sampler or its variant. It
is the Bayesian analogue to the iteratively reweighted least squares (IRLS) algorithm [31, 32] for the maximum likelihood
estimation (MLE). We define a transformed dependent variable y∗ij , and it is approximately normally distributed
y∗ij = z
′
ijβj + (yij − µij)
dηij
dµij
∼ N [z′ijβj , wij(βj)], where wij(βj) =
(
dηij
dµij
)2
Vij . (3)
Suppose the prior for βj is N(vj , R
−1
j ), and it is flat π(βj) ∝ 1 as Rj → 0. Let U(βj) and I(βj) be respectively the
score and Fisher information matrix for model (1). In general, we have U(βj) =
∑nj
j=1 zijw
−1
ij (βj)(yij − µij) dηijdµij and
I(βj) =
∑nj
j=1 zijw
−1
ij (βj)z
′
ij . Let βˆj = I(βj)
−1
∑nj
j=1 z
′
ijw
−1
ij (βj)y
∗
ij , and Σ(βj) = [I(βj) +R
−1
j ]
−1. Gamerman [33]
uses the following proposal distribution obtained from the approximate linear model (3)
β∗j ∼ N
[
Σ(βj)
(
I(βj)βˆj +Rjvj
)
,Σ(βj)
]
. (4)
However, it is not straightforward to define the transformed variable y∗ij for ordinal or nominal outcomes or when there
are nonlinear predictors. By noting that the IRLS algorithm is equivalent to Fisher’s score algorithm [31, 32], Tang [22]
proposes to sample the candidate β∗j from
β∗j ∼ N [βj +Σ(βj)(U(βj) +Rjvj),Σ(βj)]. (5)
The proposal distributions (4) and (5) are similar especially when the prior for βj is noninformative. We will use the latter
one. At each MCMC iteration, a candidate β∗j is drawn from the proposal distribution (5). We accept the move βj → β∗j
with probability Ajβ , and otherwise keep βj unchanged, where φ(β
∗
j |βj) is the PDF of the proposed distribution, and
Ajβ = min
{
1,
φ[βj |β∗j ]π(β∗j )
∏nj
i=1 fj(yij |zij ,β∗j , φj)
φ[β∗j |βj]π(βj)
∏nj
i=1 fj(yij |zij ,βj, φj)
}
.
If the dimension of βj is large, we may split βj into several blocks, and sample them separately using the above
MH sampler. There are possible alternative ways to sample βj’s. For example, for the analysis of dichotomous and
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polychotomous response using the probit or ordered probit regression, one may use either the Gibbs sampler through
the data augmentation and parameter expansion (PX) techniques [34, 35, 36, 22], or the above MH sampler. One shall
avoid using the MH within partially collapsed Gibbs (PCG) samplers [37] if (βj , φj) is drawn via the data augmentation
technique since the stationary distribution of the Markov chain may change. See Section 2.2 for further discussion.
2.1.2. Imputation of intermittent missing discrete outcomes in Step A.2.1: Let Bdi be the set of indices for intermittent
missing discrete observations, and hid the index of the first missing discrete observation for subject i. Let Kj be the
number of levels for variable j ∈ Bdi. For count data, the number of categories is infinite, and can be truncated at a large
finite value Kj at which Pr(yij > Kj) ≈ 0. There are Kdi =
∏
j∈Bdi
Kj possible combinations of yid (denoted by y
l
id,
l = 1, . . . ,Kdi). Set yid = y
l
id with probability αl/
∑Kdi
l=1 αl, where αl =
∏si
j=hid
f(yij |zij ,βj , φj ,yid = ylid).
2.1.3. Imputation of intermittent missing continuous outcomes in Step A.2.2: Sampling yic’s poses challenges. We
focus on the case when the minus Hessian matrix Vic = −
∑si
j=hic
∂2ℓij
∂yic∂y′ic
is positive definite. It holds at least for
those commonly used GLMs listed in Appendix A.1 (we will discuss later in this section how to handle the special
situation when model (1) contains interactions between two intermediate missing continuous variables), where ℓij =
log[f(yij |zij ,βj , φj)], and hic is the index of the first missing continuous observation for subject i. Section 2.2 will briefly
discuss the sampling schemes for non-positive definite Vic.
The sampling method for yic is similar to that for βj . Let ∆ic = V
−1
ic [
∑si
j=hic
∂ℓij
∂yic
]. At each MCMC iteration, a
candidate y∗ic is generated from N [yic +∆ic, V
−1
ic ], and accepted with probability Ajy , where φ[yic|y∗ic] is the PDF of
the proposal distribution, and Ajy = min
{
1,
φ[yic|y
∗
ic]
∏si
j=hci
fj(y
∗
ij |z
∗
ij ,βj,φj)
φ[y∗ic|yic]
∏si
j=hci
fj(yij |zij ,βj,φj)
}
.
If the imputation contains only the normal linear models with the conditional mean E(yij |yi1, . . . , yij−1) =∑q
k=1 xikαjk +
∑j−1
k=1 βjkyik, the MH sampler for yic becomes a Gibbs sampler (Ajy ≡ 1) and the proposed algorithm
reduced to the MDA algorithm [9, 8] for multivariate normal data (except that the priors may be different). For longitudinal
binary or ordinal outcomes, the above algorithm is identical to that of Tang [22].
If model (1) contains interactions between two intermediate missing continuous variables for a subject, Vic has a
complicated expression and may be non-positive definite. The missing values for this subject can be split into few blocks
(no two variables in an interaction term are in the same block), and imputed separately using the above MH sampler.
2.2. Extension to incorporate the skew-t / skew-normal regression or other models
2.2.1. Skew-t / skew-normal regression In Section 2.1, the continuous outcome is modeled by the normal linear regression.
For nonnormal continuous data, one simple way is to apply some transformation to make the data approximately
normally distributed [16]. However, such transformation may not always exist. Furthermore, transformation may distort
the relationship between variables [38], or make the result difficult to interpret. We model the nonnormal continuous data
by the skew-t or skew-normal regression.
A continuous random variable y is said to follow the skew-t distribution if its PDF is given by [39]
fST (y;µ, ω
2, λ, ν) =
2
ω
tν
(y − µ
ω
)
Tν+1
[
λ
y − µ
ω
√
ν + 1
ν + (y−µ)
2
ω2
]
, (6)
where µ is the location parameter, ω2 is the scale parameter, λ is the skewness parameter, and ν is d.f. It would be easier
to develop the Gibbs sampling scheme on basis of the stochastic representation for the skew-t random variable
y = µ+
1√
d
[ψW∗ + ǫ] = µ+ ψW +
1√
d
ǫ, (7)
Statist. Med. 2018, 00 1–20 Copyright c© 2018 John Wiley & Sons, Ltd. www.sim.org 5
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where d ∼ G(ν/2, ν/2), W∗ ∼ N(0, 1), W = W∗/
√
d ∼ N(0, 1/d), and ǫ ∼ N(0, 1/γ). The parameters in equations (6)
and (7) satisfy that γ = (1 + λ2)/ω2, ψ = λ/
√
γ, and that ω2 = 1/γ + ψ2, λ = ψ
√
γ. We denote the skew-t distribution
by ST (µ, ω2, λ, ν) or ST (µ, ψ, γ, ν).
The skew-t distribution becomes the skew-normal distribution [40] if we set ν ≡ ∞ (i.e. d ≡ 1). The skew-normal
distribution is suitable only for mildly or moderately nonnormal data since its maximum skewness is 0.995, and the
maximum kurtosis is 0.869 [40]. The skew-t distribution reduces to the Student’s t distribution at ψ = λ ≡ 0, and it can
not model skewed data. The skew-t distribution allows a higher degree of skewness and/or kurtosis [39].
In the sequential regression, we model the nonnormal continuous outcome yij by ST (z
′
ijβj , ψj , γj , νj)
yij = z
′
ijβj + ψjWij +
1√
dij
ǫij = z
∗′
ijβ
∗
j +
1√
dij
ǫij , (8)
where dij ∼ G(ν/2, ν/2),Wij ∼ N(0, 1/dij), z∗ij = (Wij , z′ij)′, and β∗j = (ψj ,β′j)′.
2.2.2. The prior In the skew-normal and skew-t regressions, there is a non-negligible chance that the likelihood function
is a monotone function of λj = ψj
√
γj (when other parameters are fixed), and the Bayes estimate of λj can be infinite
if a diffuse prior is used [41, 42]. The problem can be resolved by using the Jeffreys prior [41]. This prior has no
closed-form expression, but can be well approximated by the Student’s t density [43, 42]. We adopt this Student’s t
prior λj = ψj
√
γj ∼ t(0, π2/4, 1/2), and it can be expressed as a hierarchical prior
dψj ∼ G
(
1
4
,
1
4
)
and ψj |γj , dψj ∼ N
(
0,
π2
4dψjγj
)
.
We put a half t prior [44, 45] on σj =
√
1/γj with PDF π(σj) ∝ [1 + (σj/a0)2/n0]−(n0+1)/2. The prior can be
equivalently expressed as a hierarchical prior
ρj ∼ G
(
1
2
,
1
a20
)
and γj ∼ G
(n0
2
, n0ρj
)
. (9)
Setting n0 = 2 and a0 = 10
5 leads to a highly noninformative prior [45]. In the normal linear regression, one popular
prior for γj is γj ∼ G(ρ, ρ) for a small fixed ρ, and it reduces to the Jeffreys prior π(γj) ∝ γ−1j as ρ→ 0. As explained in
Appendix A.2.3, the gamma or Jeffreys prior can be quite informative or inappropriate for highly skewed data.
Inference about νj also poses challenges [46, 47]. As νj →∞, the skew-t regression converges to the skew-normal
regression, and the estimate of νj can be quite sensitive to the shape of the prior density of νj . We use the penalized
complexity (PC) prior [48] because it shows good performance in the Student’s t regression in simulation. It is obtained
through penalizing the complexity between the t and normal distributions, and is invariant to reparameterization. The PC
prior density is derived in Appendix A.2.4, which is not given by Simpson et al [48]. In the PC prior, νj is bounded below
by νl = 2. We also put an upper bound νm = 1000 on νj because the prior density can not be accurately computed at very
large νj due to rounding errors. The choice of νm has little impact on the imputation since the skew-t density function
changes little when νj > 100. Alternatively, one may use the reference prior derived by Fonseca et al [47].
2.2.3. MCMC algorithm At Step A.1 of algorithm A, we draw the model parameters using the following data
augmentation technique by treating (Wij , dij)’s as additional parameters. The MCMC scheme for the skew-t regression
can be easily modified for the Student’s t or skew-normal regression by restricting ψj ≡ 0 or (dij ≡ 1, νj ≡ ∞). The
details are given in a companion paper [49].
P1. Update ρj ∼ G((n0 + 1)/2, n0γj + 1/a20)
P2. Update dψj ∼ G(3/4, 1/4 + 2γjψ2j /π2).
6 www.sim.org Copyright c© 2018 John Wiley & Sons, Ltd. Statist. Med. 2018, 00 1–20
Prepared using simauth.cls
Y. Tang
Statistics
in Medicine
P3. Update (ψj ,βj , γj)’s from the gamma-normal distribution (18) via Gibbs sampler described in Appendix A.2.2.
P4. Update νj via a random walk MH sampler. A candidate ν˜j is drawn from log(ν˜j − νl) ∼ N [log(ν − νl), c2], and
accepted with probabilitymin
{
1,
(ν˜j−νl)π(ν˜j)
∏nj
i=1 f(yij |zij ,βj,γj ,ν˜j)
(νj−νl)π(νj)
∏nj
i=1 f(yij |zij ,βj,γj ,νj)
}
. If ν˜j > νm, it will be automatically rejected.
The tuning parameter c will be adjusted to make the acceptance probability lie roughly in the range of 30− 70%.
P5. Update (dij ,Wij) from their posterior distribution (21) for i = 1, . . . , nj .
PX1. Update (d1j , . . . , dnjj , γj) as (gd1j , . . . , gdnjj , γj/g), where g is a random sample from Equation (22)
PX2. Update (W1j , . . . ,Wnjj , ψj)→ (hW1j , . . . , hWnjj , ψj/h), where H = h2 is drawn from Equation (23)
In steps A.2.1 and A.2.2, the intermittent missing data are imputed by conditioning on (Wij , dij)’s. Given (Wij , dij)’s,
the skew-t regression (8) becomes the normal linear regression, and yic’s can still be imputed via the MH sampler
described in Section 2.1.3. As a cautious note, it is inappropriate to impute (yid,yic)’s on basis of the skew-t density
f(yij |z′ijβj , ψj , γj, νj) by integrating out (Wij , dij)’s since this forms a PCG sampler, and νj is updated via a MH sampler.
The stationary distribution of the Markov chain may change in an ordinary MH within the PCG sampler [37].
The PX technique [35, 36] is used to speed up the convergence of the MDA algorithm. Omitting steps PX1 and PX2 does
not affect the posterior distribution, but it may take more iterations for the Markov chain to reach stationarity with larger
autocorrelation between posterior samples when the data are heavy-tailed and/or highly skewed. Empirical experience
indicates that inclusion of steps PX1 and PX2 tends to make the algorithm converge faster for highly nonnormal data, and
there is no obvious gain in efficiency if the data distribution is close to normal.
We assume that Vic is positive definite. If a new regression model is employed in the imputation and it incurs a non-
positive definite Vic, some missing continuous values may be imputed simultaneously using the proposed MH sampler
if the corresponding minus Hessian matrix is positive definite, and other intermittent missing continuous values may be
imputed one at a time in Step A.2.2. Several methods can be used to impute the individual missing variable: 1) adaptive
Gibbs sampler of Gilks and Wild [50] for variables with log-concave posterior density functions, 2) Gibbs sampler of
Damlen et al [51] through the introduction of auxiliary uniform random variables, 3) random walk MH sampler.
2.3. Controlled imputation for longitudinal clinical trials
The controlled pattern imputation is often served as sensitivity analysis to assess the robustness of the conclusion obtained
from the MAR-based analysis in clinical trials [3, 28, 29, 30, 8, 22]. For simplicity, we assume the trial consists of two
treatment groups. Let xiq = gi be the treatment status (gi = 1 for the experimental treatment, 0 for control).
The missing responses yiw’s after dropout are imputed according to some MNAR mechanisms. It is a type of pattern
mixture model (PMM) since the joint distribution of yi varies by the dropout pattern
f(yi|si = s) =
s∏
j=1
fj(yij |zij ,βj, φj)
p∏
j=s+1
gj(yij |zij ,βj, φj ,∆j). (10)
In PMMs, the distribution of the outcomes before dropout
∏s
j=1 fj(yij |zij ,βj, φj) is the same as that under MAR. It
implies that the intermittent missing data are MAR. Under the MAR dropout mechanism, the distribution of the missing
data after dropout gj(yij |zij ,βj , φj ,∆j) is identical to fj(yij |zij ,βj, φj). In case of nonignorable dropout, the missing
data distribution can be specified by modifying the linear predictor ηij = z
′
ijβj , where∆j’s are the additional parameters
to capture deviation from MAR, and assumed to be known since it can not be inferred from the observed data [8].
Below, we describe two types of controlled imputations. The control-based PMM, also called “copy reference” (CR),
was initially proposed in the seminal work of Little and Yau [3], and later studied by a number of authors [29, 8, 30]. The
missing data after dropout are imputed on an as-treated basis by taking into account of the treatment actually received after
withdrawal. Specifically, it assumes that conditioning on the observed history, the statistical behavior of dropouts from the
experimental arm is the same as that of subjects on the control treatment. The imputation can be conducted by modifying
Statist. Med. 2018, 00 1–20 Copyright c© 2018 John Wiley & Sons, Ltd. www.sim.org 7
Prepared using simauth.cls
Statistics
in Medicine Y. Tang
ηij as (i.e. set the treatment status gi = xiq ≡ 0 for all subjects after dropout)
ηij =
q−1∑
k=1
xikαjk +
j−1∑
k=1
βjkyij for j > si.
In the delta-adjusted PMM, the response among subjects who discontinue the treatment may improve (e.g. subjects who
discontinue the placebo due to lack of efficacy may use other drugs available on the market) or deteriorate (e.g. subjects
who discontinue the experimental treatment due to safety) compared to subjects who remain on the same treatment. For
subjects in pattern s, the missing response can be imputed by shifting ηij for a pre-specified amount∆sjg
ηij =
q∑
k=1
xikαjk +
j−1∑
k=1
βjkyij +∆sjg for j > s. (11)
The popular tipping point analysis [26, 52] is built on the delta-adjusted imputation. It assesses how severe the departure
from MAR can be in order to overturn the MAR-based result. The analysis is the most suitable when the data contain only
one type of response variables. To reduce the number of sensitivity parameters, we set ∆sjg = ∆g for all j > s, but
other options are possible [8]. The tipping point analysis is often implemented by assuming MAR in the control arm (i.e.
∆0 = 0). The MI analysis is performed over a sequence of prespecified values for ∆1 (which leads to worse response
among dropouts from the experimental arm) in order to find the tipping point∆1 at which the statistical significance of the
treatment effect is lost [28, 8]. The FDA statisticians also recommend applying the adjustment in both treatment groups;
Please see Permutt [52] for details. The MI analysis is repeated over a range of prespecified values for (∆0,∆1) in order
to identify the region in which the treatment comparison becomes statistically insignificant. If the insignificance region is
deemed clinically implausible, one can claim that the analysis is robust to deviations from MAR.
In these PMMs, the joint likelihood of (si,yi) can be factored as{
n∏
i=1
Pr(si|xi, ζ)
}{
L(β1, φ1, . . . ,βp, φp|Yo, Yd, Yc)
n∏
i=1
p∏
j=si+1
g(yij |zij ,βj , φj ,∆j)
}
. (12)
If the parameters ζ and βj’s are separable with independent priors, the marginal posterior distribution of (βj , φj)’s in
PMMs is identical to that under MAR. The missing data yiw’s can be imputed based on the following algorithm B
B.1: Run algorithm A and collect m posterior samples of (βj , φj ,yid,yic)’s after Algorithm A converges. Posterior
samples may be retained at every t-th iteration for a large t (say t = 50) in order to achieve approximate
independence between posterior samples.
B.2: Impute yij’s (j > si) sequentially from g(yij |zij ,βj , φj ,∆j) given the model parameters drawn at Step A.1.
B.3: Draw ζ from its posterior distribution. This step can be ignored if the purpose is to impute yij’s.
3. Fully conditional specification (FCS)
In this section, we describe an alternative approach to perform the controlled imputations via FCS. The FCS [10, 14, 15]
is an imputation procedure for multivariate nonnormal data that may contain different types of response variables. The
data are imputed on a variable-by-variable basis by specifying a conditional model for each incomplete variable with all
other variables as predictors
p(yij |xi, yi1, . . . , yi,j−1, yi,j+1, . . . , yip,Θj) for j = 1, . . . , p. (13)
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Each iteration step consists of successive draw of (Θ1, Y1m), . . . , (Θp, Ypm), where Yjm denotes all missing outcomes at
visit j. In FCS,Θj is drawn from its posterior distribution given the current imputed dataset,
π(Θj |xi, yi1, . . . , yip) ∝ π(Θj)
∏
i:yij is observed
p(yij |xi, yi1, . . . , yi,j−1, yi,j+1, . . . , yip,Θj). (14)
The missing yij’s at visit j are imputed from model (13) given the current draw of Θj and the current imputed missing
values at all other visits. The FCS algorithm is similar to the traditional Gibbs sampler except that only information from
subjects with observed yij is used to drawΘj . The FCS algorithm usually converges quickly [14, 16].
It is flexible to specify the imputation model (13), which may not be fully parametric. However, it is usually unknown to
which stationary distribution the algorithm converges for complicated conditional models, or such stationary distribution
may not exist [14, 18, 19]. As evidenced in some empirical studies [14, 15, 12, 22], FCS generally performs well under
MAR despite its theoretical weaknesses. MNAR imputation can be implemented in FCS by multiplying or shifting the
imputed values by a constant amount [53], but the corresponding mechanism is hard to understand and interpret [22].
We propose the following MNAR analysis via the FCS imputation. Firstly, the intermittent missing data are imputed
via FCS under MAR. We then draw (β∗j , φ
∗
j ) for j = 1, . . . , p from model (1) given the imputed monotone dataset, and
impute the missing data yiw’s due to dropout under the specific MAR or MNAR mechanism described in Section 2.3. A
theoretical justification of the algorithm is given in Appendix A.3.
At each iteration,Θj’s and (β
∗
j , φ
∗
j )’s are drawn once from their posterior distribution. A practical way is to approximate
the posterior distribution by the asymptotic normal distribution of the MLE [14]. It can be computationally intensive to
find the MLEs particularly if a large number of imputations are needed in order to stabilize the MI result [28, 54, 55].
4. Simulation
In this simulation, we assess whether the use of intermediate outcomes can improve the MI inference in the controlled
imputation, and compare the performance of the normal versus skew-t regressions in imputing continuous outcomes. The
following priors are used in all numerical examples. In the skew-t regression, we set the prior parameter ̺ = p0/d(ν0)
on basis of the prior belief that there is a p0 = 70% chance that νj is below ν0 = 10. Empirical experience indicates that
the MI result is quite insensitive to the choice of p0. For the normal linear regression, we use the prior π(βj , γj) ∝ γ−1j .
In other regressions, the prior is π(βj) ∼ N(0, R−1j ), where Rj = diag(10−8, . . . , 10−8). In the imputation algorithm, the
binary outcomes are modeled by the logistic regression.
Two scenarios are considered. In scenario 1, we simulate H = 1, 000 datasets of size n = 300 (150 subjects per arm)
from the following model:
yi0 ∼ N(0, 1), yi1|yi0, gi ∼ N(0.5 + 0.5yi0 + gi, 1),Pr(yi2 = 1|yi0, yi1, gi) = Φ(−0.5 + 0.25yi0 + 0.8yi1),
where Φ(·) is the CDF of N(0, 1). We can view yi1 as a surrogate for yi2 in the sense that the treatment effect on yi2 is
totally mediated through yi1. Pattern is generated according to Pr(si = 0) = expit(0.3yi0 − 3), and Pr(si = 1|si ≥ 1) =
expit(0.3yi0 + yi1 − 2), where expit(x) = exp(x)1+exp(x) . The proportions of subjects in patterns 0, 1 and 2 are approximately
(4.88%, 30.53%, 64.59%). Intermittent missing data are generated by setting yij (1 ≤ j < s) to be missing with a 20%
chance among pattern s. The baseline yi0 is observed in all subjects. Scenario 2 is similar to scenario 1 except that yi1 is
generated from a skew-t distribution with parameters µi1 = 0.5− 2
√
2/π + 0.5yi0 + gi, ψ = 2, γ = 1 and ν = 10.
We assess the treatment effect on yi2. Each simulated dataset is imputed using all observed information under bothMAR
and CR by the MDA and FCS algorithms. In MDA, yi1 is assumed to be either normally distributed (labeled as “MDA-
norm”) or skew-t distributed (labeled as “MDA-ST”). We set xi = (1, yi0, gi)
′. In FCS,m = 100 datasets are imputed after
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Table 1: Comparison of MI estimates from the probit regression of yi2 on xi = (1, yi0, gi)
′ by simulation:
(a) average estimates overH = 1, 000 full datasets, where missing data are generated according to the true mechanism;
(b) sample variance ofH = 1000MI estimates;
(c) the estimates from MDA-ST and MDA-norm are the same since there is no continuous outcome in the analysis.
assumed Full(a) MDA-ST MDA-norm FCS
missing include data MI Rubin’s sample MI Rubin’s sample MI Rubin’s sample
mechanism yi1 parameter estimate estimate variance variance
(b) estimate variance variance(b) estimate total variance(b)
yi1 is normally distributed
MAR Yes intercept −0.097 −0.105 0.015 0.015 −0.106 0.015 0.015 −0.114 0.015 0.015
yi0 0.662 0.659 0.011 0.013 0.658 0.011 0.013 0.651 0.012 0.013
treatment 0.805 0.806 0.034 0.036 0.802 0.034 0.036 0.798 0.035 0.035
NO (c) intercept −0.097 −0.263 0.017 0.017 −0.271 0.017 0.017
yi0 0.662 0.617 0.013 0.015 0.599 0.013 0.015
treatment 0.805 0.734 0.041 0.042 0.730 0.040 0.041
CR YES intercept −0.100 −0.104 0.015 0.015 −0.106 0.015 0.015 −0.113 0.015 0.015
yi0 0.648 0.648 0.011 0.012 0.647 0.011 0.012 0.640 0.012 0.012
treatment 0.760 0.759 0.032 0.022 0.758 0.032 0.022 0.749 0.033 0.021
NO(c) intercept −0.100 −0.256 0.017 0.016 −0.264 0.017 0.016
yi0 0.648 0.549 0.013 0.014 0.531 0.013 0.014
treatment 0.760 0.412 0.034 0.012 0.405 0.033 0.012
yi1 follows the skew-t distribution
MAR Yes intercept −0.084 −0.081 0.013 0.013 −0.078 0.014 0.013 −0.099 0.014 0.013
yi0 0.466 0.471 0.009 0.009 0.470 0.009 0.009 0.466 0.009 0.009
treatment 0.582 0.566 0.028 0.029 0.562 0.029 0.029 0.561 0.030 0.029
NO(c) intercept −0.084 −0.421 0.019 0.019 −0.421 0.018 0.019
yi0 0.466 0.437 0.012 0.013 0.428 0.012 0.013
treatment 0.582 0.504 0.040 0.041 0.510 0.039 0.041
CR YES intercept −0.080 −0.081 0.013 0.013 −0.078 0.014 0.013 −0.099 0.014 0.013
yi0 0.461 0.464 0.008 0.008 0.465 0.009 0.008 0.461 0.009 0.009
treatment 0.547 0.537 0.027 0.020 0.535 0.027 0.020 0.524 0.028 0.019
NO(c) intercept −0.080 −0.416 0.018 0.018 −0.416 0.018 0.018
yi0 0.461 0.397 0.012 0.013 0.388 0.012 0.012
treatment 0.547 0.281 0.033 0.013 0.279 0.032 0.013
a burn-in period of 200 iterations. In MDA, m = 100 posterior samples are collected every 50th iteration after a burn-in
period of 5, 000 iterations. Each imputed dataset is analyzed by fitting a probit regression of yi2 on xi = (1, yi0, gi)
′. The
results from them imputed datasets are combined for inference via Rubin’s rule [2]. The whole analyses are then repeated
by excluding yi1 in the imputation.
The results are reported in Table 1. The full data estimate is the average of H = 1000 complete data estimates, where
the missing data after dropout are generated according to the true mechanism at the true parameter values. Compared to
FCS, both MDA-ST and MDA-norm yield slightly better results in the sense that the MI estimates are closer to the full
data estimate, and have smaller MI variance. When yi1 is normally distributed, the performance of MDA-ST is almost as
good as MDA-norm. MDA-ST exhibits some improvement over MDA-norm when yi1 is skew-t distributed.
The CR approach yields more conservative treatment effect estimates and slightly smaller MI variance estimates than
the MAR-based analysis when yi1 is included in the imputation. The differences in the MI treatment effect and variance
estimates between theMAR and CR approaches becomemore pronounced when yi1 is excluded from the analysis. Rubin’s
MI variance estimates are close to the sampling variance under MAR. In the CR approach, Rubin’s rule overestimates the
sampling variance of the treatment effect, but not the sampling variances for the intercept and the coefficient of yi0. For
example, the sample variance for the H = 1000 treatment effect estimates under CR is 0.012, but Rubin’s variance averaged
over the H = 1000 replications is 0.034 when yi1 is normally distributed, and excluded from the MDA-norm imputation.
The bias in Rubin’s variance estimator is due to the uncongeniality between the imputation and analysis models. Similar
phenomena are observed in the analysis of longitudinal continuous [55] and binary [22] outcomes.
The MI estimates are close to the full data estimates if we include yi1 in the imputation under both MAR and CR. After
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we exclude yi1 from the imputation, the treatment effect estimate reduces and Rubin’s variance estimate increases under
both MAR and CR. This is particularly obvious in the CR approach. For example, the treatment effect estimate under CR
is 0.758 when yi1 is normally distributed and included in the MDA-norm imputation, compared to 0.412 if yi1 is excluded
from the analysis. This example indicates that excluding important outcomes in the imputation may increase the bias and
variance in the parameter estimation.
5. Real data examples
5.1. Analysis of an antidepressant trial
The antidepressant clinical trial has been analyzed by several authors [28, 9, 30, 8] to illustrate the missing data
methodologies. The Hamilton 17-item rating scale for depression (HAMD-17) is collected at baseline and weeks 1, 2,
4 and 6. The dataset consists of 84 subjects on the experimental treatment and 88 subjects on placebo. The dropout rate is
24% (20/84) in the experimental arm and 26% (23/88) in the placebo arm.
The endpoint could be either a binary outcome defined as a 50% improvement in HAMD-17 from baseline, or a
continuous outcome defined as the change from baseline in HAMD-17. This binary endpoint is clinically relevant in
assessing the efficacy of an antidepressant [56]. Suppose it is of interest to estimate the effect of the test product compared
to placebo on the HAMD-17 improvement rate at week 6. For illustrative purposes, the data at week 1, 4, 6 (yi1, yi3 and
yi4) are analyzed as binary endpoints, and the data at week 2 (yi2) are treated as an “intermediate” continuous outcome.
The data are imputed under both MAR and CR in two different strategies. In one strategy, all observed data at baseline
and four post-baseline visits are employed to impute the missing responses, and xi = (1, yi0, gi). In the second strategy,
yi2 is excluded from the imputation. We impute 10, 000 datasets using MDA-ST (yi2 is assumed to be skew-t distributed),
MDA-norm (yi2 is assumed to be normally distributed) and FCS. The imputed data at week 6 are analyzed by the logistic
regression. In MDA, 10, 000 datasets are imputed from every 100th iteration after a burn-in period of 100, 000 iterations.
The convergence of the Markov chain is evidenced by the trace plots and autocorrelation function plots. The burn in period
is set to be long enough. It takes a little more time (say< 30minutes) to run the analysis, but there is less concern about the
convergence issue. This might be recommended in the analysis of pharmaceutical trials, where the analysis is prespecified,
and may not be actually conducted by a statistician. In FCS, 10, 000 datasets are imputed after a burn-in period of 200
iterations. A large number of imputations are needed to stabilize the MI results [54, 55].
Figure 1 plots the posterior density for λ2 = ψ2
√
γ2, ψ2 and ν2 in the MAD-ST algorithm when yi2 is included in
the imputation. As the median λ2 is close to 0, and the median ν2 is 16.04, the conditional distribution of yi2 given
(yi0, yi1, gi) deviates only mildly from normality. As displayed in Table 2, MDA-ST, MDA-norm and FCS yield quite
similar results. Compared to the analyses that employ yi2 in the imputation, excluding yi2 leads to larger variance of
the estimated treatment effect under MAR, and smaller treatment effect estimates and larger variance under CR. In this
example, Rubin’s variance estimates under CR is close to that under MAR.
5.2. Analysis of the NIMH schizophrenia trial
We revisit the National Institute of Mental Health (NIMH) Schizophrenia Collaborative study analyzed by Tang [22]. The
dataset contains 108 subjects on placebo, and 329 subjects on the anti-psychotic treatments. Item 79 (severity of illness)
of the Inpatient Multidimensional Psychiatric Scale (IMPS) is collected at baseline and week 1, 3 and 6, and analyzed
as a binary outcome (1: normal to mildly ill, 2= moderately to extremely ill). The dropout rate is about 35.2% in the
placebo arm, and 19.4% in the experimental arm. In addition, 21 subjects have intermittent missing data. Baseline yi0 is
not included as a covariate since about 98.6% subjects are moderately to extremely ill at baseline.
Tang [22] estimates the MI treatment effect under the MAR, CR and delta-adjusted imputation using the MDA
algorithm. We perform similar analyses using the FCS algorithm. We impute 10, 000 datasets after a burn-in period of
Statist. Med. 2018, 00 1–20 Copyright c© 2018 John Wiley & Sons, Ltd. www.sim.org 11
Prepared using simauth.cls
Statistics
in Medicine Y. Tang
−3 −2 −1 0 1 2 3
0.
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
lambda2
D
en
si
ty
−10 −5 0 5 10
0.
00
0.
05
0.
10
0.
15
psi2
D
en
si
ty
0 50 100 150
0.
00
0.
01
0.
02
0.
03
0.
04
0.
05
df2
D
en
si
ty
Figure 1: Marginal posterior density of λ2 = ψ2
√
γ2, ψ2 and ν2 (df2) from the MDA-ST algorithm in the analysis of an
antidepressant trial: (a) λ2: posterior mean −0.397 median −0.442; (b) ψ2: posterior mean −1.607, median −2.155; (c) ν2:
posterior mean 39.599, median 16.040.
Table 2: Estimated treatment effect on the response rate defined as a 50% improvement in HAMD-17 total score from baseline
to week 6 in an antidepressant trial: (a) MDA-ST and MDA-norm yield the same result since there is no continuous outcome
in the analysis after excluding yi2.
assumed MDA-ST MDA-norm FCS
missing Include MI Rubin’s MI Rubin’s MI Rubin’s
mechanism yi2 estimate variance t estimate variance t estimate variance t
MAR YES 0.619 0.354 1.750 0.614 0.353 1.737 0.616 0.356 1.731
NO(a) 0.616 0.365 1.688 0.612 0.365 1.677
CR YES 0.549 0.348 1.576 0.545 0.347 1.569 0.545 0.349 1.561
NO(a) 0.511 0.354 1.442 0.509 0.355 1.434
200 iterations. Each imputed dataset is analyzed by the logistic regression at week 6. As displayed in Table 3, the results
from FCS and MDA are similar (the MDA result is reproduced withm = 10, 000 imputations).
As pointed out by Tang [22], the tipping point does not exist if we assume MAR in the placebo arm since the treatment
comparison is still significant when we set all missing responses in the experimental arm to the worst values. We perform
the tipping point analysis with delta adjustment in both arms. Figure 2 displays the results. MDA and FCS algorithms
yield very similar results. The treatment effect at week 6 becomes insignificant only in a small region where the odds of
being “normal to mildly ill” among the dropouts from the experimental arm decrease compared to subjects who remain
on the experimental treatment, while the odds of being “normal to mildly ill” among dropouts in the placebo arm increase
compared to subjects who remain on the placebo.
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Table 3: Estimated treatment effects at week 6 and associated Rubin’s variance for the NIMH Schizophrenia trial:
(a) an adjustment of∆1 = −1 is applied to the log odds at all visits after dropout in the experimental arm.
assumed MDA FCS
missing MI Rubin’s variance MI Rubin’s variance
mechanism estimate between within total t estimate between within total t
MAR 1.417 0.024 0.060 0.084 4.886 1.407 0.025 0.060 0.085 4.825
CR 1.227 0.019 0.060 0.079 4.378 1.219 0.020 0.060 0.079 4.332
Delta(a) 1.259 0.024 0.060 0.084 4.344 1.246 0.025 0.060 0.085 4.279
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(b) FCS
Figure 2: Plot of − log10(pvalue) in the tipping point analysis of the NIMH trial with delta adjustment in both arms: the
symbols indicate the range of pvalue: ‘v’ pvalue< 0.0001, ‘x’ pvalue< 0.001, ‘o’ pvalue< 0.01, ‘*’ pvalue< 0.05
6. Discussion
We develop an efficient MDA algorithm for the imputation of multivariate nonnormal data fitted by a sequence of GLMs,
skew-normal regression and/or skew-t regression. The algorithm can handle different variable types and nonnormal
continuous outcomes. Its extension to include other models is discussed. We apply the algorithm to the controlled
imputations for the sensitivity analysis of longitudinal clinical trials. Due to the computational resource constraint, only
one simulation study is conducted. It demonstrates that the inclusion of important intermediate outcomes in the imputation
can reduce the bias and improve the precision in estimating the treatment effect.
We also describe a heuristic approach to implement the controlled imputation via FCS. While it is flexible to specify the
conditional distribution for each individual variable given all other variables, a theoretical weakness of FCS is that there
might not exist a joint stationary distribution that is consistent with these conditional distributions [15, 18, 19, 57]. The
result may be affected by the order in which the variables are imputed [19]. It is unclear under what situations FCS works
well, and its performance is mainly evaluated by simulations. The FCS can be slightly less efficient than the MCMC-based
method [16, 23, 57], and this is also observed in our numerical examples.
In the CR approach, the missing data after dropout are imputed by using the observed outcomes as predictors, and
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the treatment benefit obtained prior to dropout will not disappear over a short period of time after dropout [8]. The CR
assumption may not be appropriate for the situation where all the benefit from the treatment is gone immediately after
treatment discontinuation. There are many potential ways to assume how the disease progresses after dropout based on
the exposure-response relationship and/or dropout reasons. The MDA algorithm is suitable for any PMMs that assume the
same observed data distribution as that under MAR [8].
A novel MCMC algorithm is proposed for univariate skew-t and skew-normal regressions. For skewed and/or fat-tailed
longitudinal data, the sequential regression introduces p pairs of latent variables (Wij , dij)’s per subject. In a companion
paper [49], we describe a MDA algorithm for multivariate skew-t and skew-normal regressions. The multivariate model
is more parsimonious, and the latent variables (Wi, di) are shared by all observations within a subject. The skew-t and
skew-normal regressions can also be incorporated into FCS to handle nonnormal continuous outcomes.
There are several potential advantages to use the skew-t regression to impute nonnormal continuous data. Firstly, the
inference is more robust to extreme outliers [49]. Secondly, it may improve the precision of the treatment effect estimate,
and this is evidenced in our simulation. Previous studies [58, 38] indicate that imputing skewed continuous data using a
normal model performs well in estimating the linear regression coefficients (this can be justified by Tang’s [55] theoretical
result that the MI and likelihood-based inferences are asymptotically equivalent for multivariate continuous outcomes
under MAR), but does a poor job of estimating the shape parameters such as percentiles and skewness coefficients [58].
We expect that the performance may be improved by using the nonnormal imputation model.
The proposed imputation procedure has some limitations. Firstly, it assumes the intermittent missing data are MAR. In
general, the assumption is reasonable since the intermittent missingness is often due to reasons (e.g. scheduling difficulty)
unrelated to the patients’ health conditions, or can be predicted given the observed outcomes. In a well-conducted trial,
typically only a small proportion of patients have missing data before dropout, and the MAR assumption is not expected
to have a big impact on the analysis result if the intermittent missing data are MNAR [7, 8]. However, the inference
can be misleading if there is a large amount of nonignorable intermittent missing data. Secondly, the approach is fully
parametric, and its performance under model misspecification requires further investigation. Semiparametric techniques
may be incorporated into the imputation procedure. For example, one may fill in the intermittent missing data using the
MDA algorithm, and then employ the predictive mean matching (PMM [59]) or local residual draw (LRD [59]) methods
to impute the missing data after dropout. In both PMM and LRD, the posterior samples of the model parameters from the
MDA algorithm can be used directly to impute the missing values, and there is no need to regenerate them based on the
augmented monotone data. The predicted values for the incomplete variable are commonly estimated by the normal linear
regression [59], but they can also be obtained from the skew-normal or skew-t regression. It is currently unclear how to
efficiently impute the intermittent missing data by PMM or LRD.
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A. Appendix
A.1. Several commonly used generalized linear models
We review several GLMs commonly used to analyze continuous, binary, ordinal, nominal and count data. Technical
details are provided for the MDA algorithm. Throughout, let f(yij |zij ,βj , φj) denote the PDF or probability mass
function (PMF) of yij , and ℓij = log[f(yij |zij ,βj, φj)]. Let β˜j = (β′j , 0, 0, . . . , 0)′ be a (q + p)× 1 vector for categorical
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outcomes. Thus ηij = z
′
ijβj = (xi1, . . . , xiq, yi1, . . . , yip)β˜j . We define β˜j = (β
′
j ,−1, 0, . . . , 0)′ for a continuous
outcome. Then yij − z′ijβj = −(xi1, . . . , xiq, yi1, . . . , yip)β˜j . Let βic be a subvector of β˜j containing all elements
corresponding to the intermittent missing continuous values for subject i. Let H(yic) = − ∂
2ℓij
∂yic∂y′ic
.
A.1.1. Normal linear regression for continuous outcomes The PDF is f(yij |zij ,βj , γj) ∝ √γj exp[− γj(yij−θij)
2
2 ],
where b(θij) = θ
2
ij/2, a(φj) = 1/γj , θij = ηij = z
′
ijβj . We have
∂ℓij
∂yic
= γj(yij − θij)βic, and H(yic) = − ∂
2ℓij
∂yic∂y′ic
= γjβicβ
′
ic.
For the skew-t regression described in Section 2.2, the above formulae can be modified by replacing θij by
z′ijβj + ψjWij and γj by dijγj .
A.1.2. Logistic regression with logit link for binary outcomes We code the binary outcome as 1 or 2. The PMF is
f(yij |zij ,βj) = πI(yij=1)ij (1− πij)I(yij=2) = exp[I(yij = 1)θij − b(θij)], where a(φj) = 1, θij = ηij = z′ijβj ,
πij = Pr(yij = 1|zij ,βj) = 11+exp(−z′ijβj) , and b(θij) = log[1 + exp(θij)]. Then
∂ℓij
∂βj
= [I(yij = 1)− πij ]zij and I(βj) = E(− ∂
2ℓij
∂βj∂β′j
) = πij(1− πij)zijz′ij ,
∂ℓij
∂yic
= [I(yij = 1)− πij ]βic, and H(yic) = − ∂
2ℓij
∂yic∂y′ic
= πij(1− πij)βicβ′ic.
A.1.3. Proportional odds models for ordinal outcomes withK levels We use the same notations as Tang [22]. Let
γijk = Pr(yij ≤ k|zij) =
exp(cjk+z
′
ijβj)
1+exp(cjk+z
′
ijβj)
for 1 ≤ k ≤ K − 1, γij0 = 0, γijK = 1, and
πijk = Pr(yij = k|zij) = γijk − γijk−1 , where cj1 = 0 (it is absorbed into the intercept) and cjk =
∑k
t=2 exp(djt) [i.e.
djk = log(cjk − cjk−1)]. Then f(yij |zij ,βj) =
∏K
k=1 π
I(yij=k)
ijk
and ℓij =
∑K
k=1 I(yij = k) log(πijk ).
Tang [22] updates ßj = (dj2 , . . . , djK−1 , αj1, . . . , αjq , βj1, . . . , βj,j−1)
′ by the MH scheme, where d∗jk = exp(djk) at
k ≤ j, d∗jk = 0 if k > j,
∂γijk
∂ßj
= γijk(1− γijk )[d∗j2 , . . . , d∗jK−1 , z′ij ]′,
∂γijk
∂ßj
≡ 0 at k = 0, K , ∂πijk∂ßj =
∂γijk
∂ßj
− ∂γijk−1∂ßj ,
∂ℓij
∂ßj
=
K∑
k=1
π−1ijk
∂πijk
∂ßj
I(yij = k) and I(ßj) = E(− ∂
2ℓij
∂ßj∂ß′j
) =
K∑
k=1
π−1ijk
[
∂πijk
∂ßj
] [
∂πijk
∂ßj
]′
.
Note that
∂γijk
∂yic
= γijk(1 − γijk)βic at k = 0, . . . ,K , and ∂πijk∂yic =
∂γijk
∂yic
− ∂γijk−1∂yic = πijk (1− γijk − γijk−1 )βic. Thus
∂ℓij
∂yic
=
K∑
k=1
I(yij = k)(1− γijk − γijk−1 )βic and H(yic) =
K∑
k=1
I(yij = k)[γijk (1− γijk) + γijk−1 (1− γijk−1 )]βicβ′ic.
A.1.4. Multinomial logistic regression for nominal outcomes with K levels Let
πijk = Pr(yij = k) =
exp(z′ijβjk )
1+
∑K−1
k=1
exp(z′ijβjk )
for 1 ≤ k ≤ K − 1, and πijK = Pr(yij = K) = 11+∑K−1
k=1
exp(z′ijβjk )
. Let
θijk = z
′
ijβjk and βj = (β
′
j1
, . . . ,β′jK−1)
′. Then f(yij |zij ,βj) =
∏K
k=1 π
I(yij=k)
ijk
and
ℓij =
∑K−1
k=1 I(yij = k)θijk − log[1 +
∑K−1
k=1 exp(θijk )].
Let piij = (πij1 , . . . , πijK−1 )
′ and Iyij = (I(yij = 1), . . . , I(yij = K − 1))′ be a vector of indicator variables.
∂ℓij
∂βj
= (Iyij − piij)⊗ zij and I(βj) = E(−
∂2ℓij
∂βj∂β′j
) = [diag(piij)− piijpi′ij ]⊗ (zijz′ij),
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∂ℓij
∂yic
=
K−1∑
k=1
[I(yij = k)− πijk ]βick andH(yic) =
K−1∑
k=1
πijkβickβ
′
ick
− (
K−1∑
k=1
πijkβick)(
K−1∑
k=1
πijkβick)
′,
where βick is a sub-vector of (β
′
jk
, 0, . . . , 0) corresponding to the intermittent missing continuous values for subject i.
A.1.5. Poisson regression for count data The PMF is f(yij |zij ,βj) = µ
yij
ij exp(−µij)
yij !
, where θij = ηij = z
′
ijβj ,
b(θij) = exp(θij), and µij = b
′(θij) = exp(z
′
ijβj). We get
∂ℓij
∂βj
= [yij − exp(z′ijβj)]zij and I(βj) = E[−
∂2ℓij
∂βj∂β′j
] = exp(z′ijβj)zijz
′
ij ,
∂ℓij
∂yic
= [yij − exp(z′ijβj)]βic and H(yic) = −
∂2ℓij
∂yic∂y′ic
= exp(z′ijβj)βicβ
′
ic.
A.1.6. Negative binomial regression for overdispersed count data The PMF is
f(yij |zij ,βj, κj) = Γ(yij+1/κj)
yij ! Γ(1/κj)κ
1/κj
j
µ
yij
ij
[1/κj+µij ]
yij+1/κj
, where µij = exp(z
′
ijβj). We have
∂ℓij
∂βj
=
yij − µij
1 + κj µij
zij and I(βj) = E[− ∂
2ℓij
∂βj∂β′j
] =
µij
1 + κj µij
zijz
′
ij ,
∂ℓij
∂yic
=
yij − µij
1 + κj µij
βic and H(yic) = − ∂
2ℓij
∂yic∂y′ic
=
(1 + κj yij)µij
(1 + κj µij)2
βicβ
′
ic.
A.2. Posterior distributions in the skew-t regression
The joint posterior distribution of (νj , ρj , γj, dψj , ψj ,βj, dij ’s,Wij ’s) is
f(νj , dij ’s,Wij ’s,βj, ψj , γj , dψj , ρj |Yo, Yd, Yc)
∝π(νj)π(ρj)π(γj |ρj)π(dψj )π(ψj |dψj , γj)
j=nj∏
i=1
[f(dij)f(Wij |dij)f(yij |zij ,βj , γj , ψj , dij ,Wij)]
∝π(νj)[ρ
1
2−1
j exp(−
ρj
a20
)] [(n0ρj)
n0
2 γ
n0
2 −1
j exp(−n0ρjγj)] [d
1
4−1
ψj
exp(−dψj
4
)]
[√
4dψjγj
π2
exp(−4dψjγjψ
2
j
2π2
)
]
nj∏
i=1
{
d
ν
2−1
ij exp(−
dijν
2
) d
1
2
ij exp(−
dijW
2
ij
2
)
√
dijγj exp
[
−dijγj(yij − z
′
ijβj − ψjWij)2
2
]}
.
(15)
A.2.1. Posterior distributions of ρj and dψj By Equation (15), the posterior distributions of ρj and dψj are both gamma
f(ρj|Yo, Yd, Yc, γj , νj , dψj , ψj ,βj , dij’s,Wij’s) ∝ ρ
1+n0
2 −1
j exp[−ρj(
1
a20
+ n0γj)], (16)
f(dψj |Yo, Yd, Yc, νj , ρj , γj , ψj ,βj , dij’s,Wij’s) ∝ d
3
4−1
ψj
exp[−dψj (
1
4
+
2γjψ
2
j
π2
)]. (17)
A.2.2. Generation of normal-gamma random variables Suppose (β, γ) ∼ γm/2−1 exp(−γβ˜′Dβ˜/2), where β is a l× 1
vector, β˜ = (−β′, 1)′, andD is a (l + 1)× (l + 1) positive definite symmetric matrix, Let the Cholesky decomposition of
D be denoted byD = LL′, and C = L−1. Let tj
i.i.d∼ N(0, 1), t2l ∼ χ2m−l. Let (h1, . . . , hl)′ = C′(t1, . . . , tl)′. Tang [9]
shows that (β, γ) can be generated as γ = h2l and β = −(h1, . . . , hl−1)′/hl.
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A.2.3. Posterior distribution of (ψj ,βj, γj) Let z˜
∗
ij = (Wij ,x
′
i, yi1, . . . , yij)
′, β∗j = (ψj ,β
′
j)
′, β˜∗j = (−β∗
′
j , 1)
′,
Dj =
∑
i≤nj
dij z˜
∗
ij z˜
∗′
ij and Ej = diag(
4dψj
π2 , 0, . . . , 0, 2n0ρj). The posterior distribution of (β
∗
j , γj) is gamma-normal,
f(β∗j , γj |νj , ρj , dψj , Yd, Yc, Yo, dij ’s,Wij ’s) ∝ γ
nj+n0+1
2 −1
j exp
[
−γjβ˜
∗′
j (Dj + Ej)β˜
∗
j
2
]
. (18)
The marginal distribution of γj is gamma and the conditional distribution of (ψj ,βj) given γj is normal. They can be
generated using the Gibbs sampler described in Appendix A.2.2.
For γj , we prefer the prior specified in Equation (9). Below we explain why we don’t use the gamma prior γj ∼ G(ρ, ρ)
commonly used in the linear regression. For highly skewed data, λj = ψj
√
γj is large, and σ
2
j = 1/γj is close to 0. We
expect that both the residual sum of square error Sˆj from model (8) and dψj are close to 0. Under the gamma prior,
Ej = diag(
4dψj
π2 , 0, . . . , 0, 2ρ)→ E∗j = diag(0, . . . , 0, 2ρ). The marginal posterior distribution of γj is approximately a
gamma distribution with rate parameter ρ+ Sˆj/2 [this holds exactly if Ej = E
∗
j , or if a flat prior is used for ψj]. The
gamma prior can be quite informative when Sˆj is relatively small compared to ρ. We do not use the Jeffreys prior
π(γj) ∝ γ−1j since the matrixDj + Ej can be nearly singular for highly skewed data, causing numerical problems.
A.2.4. Prior and posterior distributions for νj We firstly derive the PC prior for νj . Let f(x) and h(x) denote
respectively the PDF of the t distribution t(µ, ν−2ν σ
2, ν) and normal distribution N(µ, σ2). It is easy to show [49] that∫
f(x) log f(x)dx = log Γ(ν+12 )− log Γ(ν2 )− ν+12 [Ψ(ν+12 )−Ψ(ν2 )]− 12 log |σ2| − 12 log(νj − 2)− 12 log(π), and∫
f(x) log h(x)dx = − 12 log(2π)− 12 log |σ2| − 12 . The Kullback-Leibler distance between the two distributions is
KL(ν) =
1
2
[1 + log(
2
ν − 2)] + log Γ(
ν + 1
2
)− log Γ(ν
2
)− ν + 1
2
[Ψ(
ν + 1
2
)−Ψ(ν
2
)].
By the definition of the PC prior [48], d(ν) =
√
2KL(ν), and the PC prior density is
π(ν) ∝ ̺ exp[−̺ d(ν)] |∂d(ν)
∂ν
|,
where Γ(·), Ψ(·) and Ψ′(·) are the gamma, digamma and trigamma functions, b(ν) = Ψ(ν+12 )−Ψ(ν2 ),
d(ν) =
√
1 + log(
2
ν − 2) + 2 log
Γ(ν+12 )
Γ(ν2 )
− (ν + 1) b(ν) and |∂d(ν)
∂ν
| =
1
ν−2 +
ν+1
2 [Ψ
′(ν+12 )−Ψ′(ν2 )]
4d(ν)
.
The posterior distribution of νj is given by
π(νj |γj , ψj ,βj , Yd, Yc, Yo) ∝ π(νj)
nj∏
i=1
t(y∗ij ; νj)Tν+1
[
λj y
∗
ij
√
νj + 1
νj + y∗2ij
]
I(νj > νl), (19)
where ω2ij = γ
−1
j + ψ
2
j , y
∗
ij = (yij − z′ijβj)/ωij , and λj = ψj√γj .
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A.2.5. Posterior distribution of (Wij , dij) The posterior distribution of (Wij , dij) given (νj ,βj, ψj , γj , dψj , ρj ,yi) is
pos(dij ,Wij) ∝ d
ν+2
2 −1
ij exp[−dij
ν +W2ij
2
] exp[−γjdij(yij − z
′
ijβj − ψjWij)2
2
]I(Wij > 0)
∝
{
d
ν+1
2 −1
ij exp[−dij
bd
2
]
}{
d
1
2
ij exp[−
dijVw(Wij − µw)2
2
]
}
I(Wij > 0)
∝



1 + (Wij−µw)
2
bd/(baVw)
ba


− ba+12
I(Wij > 0)


{[
b∗d
2
] ba+1
2
d
ba+1
2 −1
ij exp[−dij
b∗d
2
]
}
,
(20)
where y∗∗ij = yij − z′ijβj , Vw = γjψ2j + 1, µw =
γjψjy
∗∗
ij
Vw
, ba = ν + 1, bd = ν +
γjy
∗∗2
ij
Vw
, and b∗d = bd + (Wij − µw)2Vw.
In Equation (20), the marginal distribution ofWij is a positive t distribution t
+(µw ,
bd
baVw
, ba), and the conditional
distribution of dij givenWij is G( ba+12 ,
b∗d
2 ). They can be generated as
d∗ij ∼ G(
ba
2
,
bd
2
),Wij |d∗ij ∼ N+(µw,
1
d∗ijVw
), dij |Wij ∼ G(ba + 1
2
,
b∗d
2
). (21)
Note that in Equation (20), the marginal distribution of dij is not gamma.
A.2.6. Generation of random variables from f(g) ∝ gc−1 exp(−bg) exp(−ag ) with c > 0, b > 0 and a ≥ 0 We use the
acceptance and rejection algorithm. A candidate g∗ is drawn from G(c, d) with PDF h(g) ∝ gc−1 exp(−dg), where
r = b− d ≥ 0. Thus f(g)/h(g) = exp(−rg − a/g) ≤ exp[−2√ra]. We accept g∗ with probability
exp[−(√rg −
√
a/g)2]. We set
√
a/r = E(g∗) = c/d. That is r = b e−1e+1 and d =
2b
e+1 , where e =
√
1 + 4ab/c2. The
acceptance rate is typically higher than 0.9 in our numerical examples. When a = 0, we have e = 1, b = d and the
acceptance is 1.
A.2.7. Posterior distribution of g and h in steps PX1 and PX2 The posterior distribution of g under the Haar prior
π(g) ∝ g−1 with Jacobian gnj−1 is given by
pos(g) ∝ gnj−1g−1f(νj , g d1j , . . . , g dnjj ,W1j , . . . ,Wnjj ,βj , ψj ,
γj
g
, dψj , ρj |Yo, Yd, Yc)
∝ g
nj(νj+1)−(n0+1)
2 −1 exp
[
−g
∑nj
i=1 dij(νj +W
2
ij)
2
]
exp

−γj(n0ρj + 2dψjψ
2
j
π2 )
g

 . (22)
The posterior distribution of h under the Haar prior π(h) ∝ h−1 with Jacobian hnj−1 is given by
pos(h) ∝ hnj−1h−1f(νj , d1j , . . . , dnjj , hW1j , . . . , hWnjj ,βj,
ψj
h
, γj , dψj , ρj |Yo, Yd, Yc)
∝ hnj−2 exp
[
−h2
∑nj
i=1 dijW
2
ij
2
]
exp
[
−2dψjγjψ
2
j
h2π2
]
.
Therefore, the posterior distribution of H = h2 is
pos(H) ∝ pos(h) 1√
H
∝ H
nj−1
2 −1 exp
(
−H
∑nj
i=1 dijW
2
ij
2
)
exp
(
−2dψjγjψ
2
j
π2H
)
. (23)
We can draw g and H = h2 using the method described in Appendix A.2.6.
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A.3. Justification of the FCS-MNAR algorithm
The MCMC algorithm in Section 2 can be summarized as below
• Draw (βj’s, φj’s, Yd, Yc) from their posterior distribution given Yo until the MDA algorithm converges
• Impute Yw given (βj’s, φj’s, Yd, Yc, Yo).
The following variant of the algorithm is valid, but less efficient since an additional step is needed to draw (β∗j , φ
∗
j )’s
• Draw (βj’s, φj’s, Yd, Yc) from their posterior distribution given Yo until the MDA algorithm converges
• Impute Yw given (Yd, Yc, Yo). This can be done by drawing (β∗j , φ∗j )’s given (Yd, Yc, Yo), and sampling Yw from
their posterior distribution given (β∗j ’s, φ
∗
j ’s, Yd, Yc, Yo).
The idea underlying the FCS-MNAR algorithm is similar to the above variant except that the intermittent missing
outcomes in the first step are imputed by FCS.
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